Real-world data showed that bivalent messenger RNA vaccines against SARS-CoV-2 provided “significant additional protection” against symptomatic COVID-19 among people who had received two, three or four previous monovalent doses.
The Biden administration's campaign to boost Americans ahead of an expected winter wave is lagging, with about 11 percent of people having gotten a bivalent booster.